Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

SLDB holding history

Solid Biosciences Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLDB overviewAll 13F holders of SLDBFull Q2 2026 holdings

Shares (Q2 2026)
188,347
Value
$1.88M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SLDB by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026188,347$1.88M<0.1%+89,369+90.3%AddedHolders
Q1 202698,978$712.6K<0.1%−812,431−89.1%ReducedHolders
Q4 2025911,409$5.14M<0.1%+187,264+25.9%AddedHolders
Q3 2025724,145$4.47M<0.1%−48,150−6.2%ReducedHolders
Q2 2025772,295$3.76M<0.1%+657,600+573.3%AddedHolders
Q1 2025114,695$424.4K<0.1%+20,228+21.4%AddedHolders
Q4 202494,467$377.9K<0.1%+82,471+687.5%AddedHolders
Q3 202411,996$83.6K<0.1%+5,126+74.6%AddedHolders
Q2 20246,870$39.0K<0.1%−7,379−51.8%ReducedHolders
Q1 202414,249$189.8K<0.1%+10,225+254.1%AddedHolders
Q4 20234,024$24.7K<0.1%+4,009+26,726.7%AddedHolders
Q3 202315$38<0.1%−178−92.2%ReducedHolders
Q2 2023193$1.01K<0.1%+27+16.3%AddedHolders
Q1 2023166$787<0.1%00.0%UnchangedHolders
Q4 2022166$893<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q3 20222,500$1.00K<0.1%00.0%UnchangedHolders
Q2 20222,500$2.00K<0.1%00.0%UnchangedHolders
Q1 20222,500$3.00K<0.1%−39,008−94.0%ReducedHolders
Q4 202141,508$72.0K<0.1%+35,403+579.9%AddedHolders
Q3 20216,105$15.0K<0.1%+825+15.6%AddedHolders
Q2 20215,280$19.0K<0.1%−6,579−55.5%ReducedHolders
Q1 202111,859$66.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.